hesperidin has been researched along with Overweight in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M | 1 |
de Groot, E; Garcés-Rimón, M; Masclee, AA; Possemiers, S; Salden, BN; Stevens, YR; Troost, FJ; Winkens, B | 1 |
3 trial(s) available for hesperidin and Overweight
Article | Year |
---|---|
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult | 2016 |
Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cell Adhesion Molecules; Dietary Supplements; Double-Blind Method; Down-Regulation; Endothelium, Vascular; Female; Hesperidin; Humans; Male; Middle Aged; Obesity; Overweight; P-Selectin; Postprandial Period; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2016 |